Navigation Links
Waters Publishes Rapid and Specific Method of Detection for Melamine in Infant Formula and Liquid Milk, in Support of China's Ministry of Science and Technology
Date:10/17/2008

MILFORD, Mass., Oct. 17 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT) today published a rapid method for the detection of melamine in infant formula and liquid milk as outlined by requirements of China's Ministry of Science and Technology (M.O.S.T.). The new method uses Waters(R) ACQUITY(R) TQD, liquid chromatography combined with tandem quadrupole mass spectrometry (UPLC/MS/MS) operated in Multiple Reaction Monitoring (MRM) mode, and Waters MassLynx(TM) 4.1 Software with IntelliStart(TM) technology for data acquisition and MS parameters optimization.

Following an increased incidence of kidney stones and renal failure in infants in China believed to be associated with the ingestion of contaminated infant formula, M.O.S.T. issued guidelines for the development of melamine detection methods to be used throughout the nation. Specifically, M.O.S.T. is seeking accurate, reproducible detection of melamine of less than or equal to 2 mg/kg (ppm). Moreover, authorities in the US have declared that no tolerance can be set for the presence of melamine in infant formula. This indicates the need for an analytical method capable of accurately quantifying melamine across a wide range of concentrations.

Waters published method meets or exceeds these requirements. Specifically, Waters UPLC/MS/MS detection method can detect melamine contamination as low as 1 microgram/Kg (ppb) with an achievable sample throughput better than one sample every 15 minutes.

"Waters has a history of working with China's Ministry of Science and Technology by listening to their needs and providing solutions," said James Willis, Senior Director, Chemical Analysis Business for the Waters Division. "Analytical instrument companies in China are all providing training to assist food safety scientists throughout the nation. What is most important is that the foundation of this training is a scientifically sound, reproducible method that meets the requirements of China's highest scientific authorities for detection of melamine in milk and infant formula -- and that is what Waters has published today."

The rapid method for the screening and confirmation of melamine contamination in infant formula and liquid milk by UPLC/MS/MS, can be found on Waters' Website at: http://www.waters.com/waters/library.htm?locale=en_US&cid=514887&lid=10087429&xcid =91 86 (due to the length of the URL, please copy and paste into web browser).

About Waters Corporation (http://www.waters.com)

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.47 billion in 2007 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, UltraPerformance LC, UPLC, ACQUITY UPLC, IntelliStart, MassLynx, and ACQUITY TQD are trademarks of Waters Corporation.

Media Contact

Brian J. Murphy

Public Relations

+1 508-482-2614

brian_j_murphy@waters.com


'/>"/>
SOURCE Waters Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Silver Lake Research Unveils Watersafe(R) Well Water Test Kit
2. Waters Brings Advanced Laboratory Data Management to Microsofts BioIT Alliance
3. David H. Murdock Research Institute Taps Waters for Laboratory Technology
4. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
5. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
6. Consortium publishes Phase II map of human genetic variation
7. The Lancet Publishes Vasogens ACCLAIM Results
8. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
9. The Lancet Publishes Results From Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
10. Springer publishes anthology with the Nanoethics Group
11. The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... -- This report analyzes the worldwide markets for Biofuel Enzymes ... Cellulase, and Others. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... of World. Read the full report: ... for the period 2015 through 2022. Also, a six-year historic ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... with catheters associated with peritoneal dialysis, announced today that it has published the ... connection system in Peritoneal Dialysis International (PDI), the official Journal of the ...
(Date:2/18/2017)... Kurzlehrgang mit Fokus auf Assay zum ... metaproteomische Analyse des Darm-Mikrobioms bei Säuglingen dar   ... Wie ... Peretz , Scientific Director bei ImmuneCarta, einen Kurzlehrgang zu ... intrazellulärer Zytokine bei adoptiven Zelltherapie-Studien im Rahmen der jährlich ...
(Date:2/17/2017)... , Feb. 17, 2017  BioGenex, a global ... development of a novel system for quantitative immunohistochemistry ... the University of Rochester (NY, USA) and Konica-Minolta ... new system is able to accurately quantify the ... (Human epidermal growth factor receptor-2) in clinical samples. ...
Breaking Biology Technology:
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion in ... a compound annual growth rate (CAGR) of 24.0% through 2021. ... for synthetic biology. - Analyses of global market trends, with ... annual growth rates (CAGRs) through 2021. - Coverage of core ...
(Date:2/7/2017)... WARSAW, Ind. , Feb. 7, 2017 ... global leader in musculoskeletal healthcare, will present at the ... Lotte New York Palace Hotel on Wednesday, February 15, ... A live webcast of the presentation can be accessed ... for replay following the conference via Zimmer Biomet,s Investor ...
Breaking Biology News(10 mins):